IDiyas

For the Inventor, By the Inventor

Nagano, Japan

Satoshi Akahane

USPTO Granted Patents = 11 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Azumino, JP (2008)
  • Matsumoto, JP (2008)
  • Nagano, JP (2007 - 2009)
  • Mtsumoto, JP (2008 - 2010)

Company Filing History:

goldMedal11 out of 176 
 
Kissei Pharmaceutical Co., Ltd.
 patents

Years Active: 2007-2010

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7674938 - Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof (2010-03-09),
2. 7563822 - Agents for the prevention or treatment of renal diseases (2009-07-21),
3. 7446128 - Agent for treating interstitial cystitis (2008-11-04),
4. 7423185 - Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof (2008-09-09),
5. 7417169 - Amino alcohol derivatives, medicinal composition containing the same, and use of these (2008-08-26),
6. 7402692 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-07-22),
7. 7396954 - Intermediates in producing phenoxyacetic acid preventives and method of using the same (2008-07-08),
8. 7393968 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-07-01),
9. 7329771 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-02-12),
10. 7256215 - Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative (2007-08-14),
11. 7208520 - Crystals of hydroxynorephedrine derivative (2007-04-24),

Title: Innovations of Satoshi Akahane: A Pioneer in Pharmaceutical Chemistry

Introduction: Satoshi Akahane is a notable inventor based in Nagano, Japan, recognized for his significant contributions to pharmaceutical chemistry. With an impressive portfolio of 11 patents, Akahane has focused on developing novel compounds that have the potential to improve health outcomes, particularly in renal diseases.

Latest Patents: Among his latest innovations, Akahane has filed patents related to amino alcohol derivatives and pharmaceutical compositions containing these compounds. One of his standout inventions includes a range of compounds characterized by a general formula that showcases potent and selective β3-adrenoceptor stimulating activities. This compound not only opens avenues for new therapeutic applications but also supports the development of pharmaceutical compositions designed for effective treatment. Another notable patent involves agents for the prevention or treatment of renal diseases, centered around a 5-amidino-2-hydroxybenzenesulfonamide derivative, which has been indicated as an active ingredient for renal health.

Career Highlights: Satoshi Akahane is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to push the boundaries of innovation in drug development. His work emphasizes the significance of targeted therapies that can address specific medical needs, particularly in the field of nephrology.

Collaborations: Throughout his career, Akahane has collaborated with esteemed colleagues, including Junichi Kobayashi and Takehiro Ishikawa. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds, showcasing the power of teamwork in the realm of scientific innovation.

Conclusion: Satoshi Akahane's work stands as a testament to the impact of innovations in pharmaceuticals. His dedication to creating effective compounds for treatment underscores the importance of continual research and development in the medical field. As he continues to explore new frontiers in pharmaceutical chemistry, his patents are likely to play a crucial role in shaping future therapeutic landscapes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…